Med Biogene Stock Market Value
| MBGNF Stock | USD 0.01 0.00 0.00% |
| Symbol | Med |
Med BioGene 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Med BioGene's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Med BioGene.
| 11/30/2025 |
| 12/30/2025 |
If you would invest 0.00 in Med BioGene on November 30, 2025 and sell it all today you would earn a total of 0.00 from holding Med BioGene or generate 0.0% return on investment in Med BioGene over 30 days. Med BioGene is related to or competes with Prenetics Global, Nuwellis, P3 Health, Dermata Therapeutics, Aclarion, and Purple Biotech. Previously, it was engaged in the life science business with a focus on the development and commercialization of genomic... More
Med BioGene Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Med BioGene's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Med BioGene upside and downside potential and time the market with a certain degree of confidence.
Med BioGene Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Med BioGene's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Med BioGene's standard deviation. In reality, there are many statistical measures that can use Med BioGene historical prices to predict the future Med BioGene's volatility.Med BioGene Backtested Returns
We have found three technical indicators for Med BioGene, which you can use to evaluate the volatility of the firm. The company secures a Beta (Market Risk) of 0.0, which conveys not very significant fluctuations relative to the market. the returns on MARKET and Med BioGene are completely uncorrelated.
Auto-correlation | 0.00 |
No correlation between past and present
Med BioGene has no correlation between past and present. Overlapping area represents the amount of predictability between Med BioGene time series from 30th of November 2025 to 15th of December 2025 and 15th of December 2025 to 30th of December 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Med BioGene price movement. The serial correlation of 0.0 indicates that just 0.0% of current Med BioGene price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.0 | |
| Spearman Rank Test | 1.0 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Med BioGene lagged returns against current returns
Autocorrelation, which is Med BioGene pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Med BioGene's pink sheet expected returns. We can calculate the autocorrelation of Med BioGene returns to help us make a trade decision. For example, suppose you find that Med BioGene has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Med BioGene regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Med BioGene pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Med BioGene pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Med BioGene pink sheet over time.
Current vs Lagged Prices |
| Timeline |
Med BioGene Lagged Returns
When evaluating Med BioGene's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Med BioGene pink sheet have on its future price. Med BioGene autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Med BioGene autocorrelation shows the relationship between Med BioGene pink sheet current value and its past values and can show if there is a momentum factor associated with investing in Med BioGene.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
| DD | Dupont De Nemours | |
| CRDO | Credo Technology Group | |
| GOOG | Alphabet Inc Class C | |
| BAC | Bank of America | |
| CRM | Salesforce |
Other Information on Investing in Med Pink Sheet
Med BioGene financial ratios help investors to determine whether Med Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Med with respect to the benefits of owning Med BioGene security.